{
  "docId": "019de077-5eda-7429-9622-6655c69874f4",
  "docSlug": "189ccbf1ac7d3b2805c8850962309310",
  "documentTitle": "Legend Biotech | Results Presentation Deck | 17 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 17,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "before_after",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "Data from CARTITUDE-4 study update presented at International Myeloma Society 2024.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-5eda-7429-9622-6655c69874f4/6",
  "deckHref": "/decks/019de077-5eda-7429-9622-6655c69874f4",
  "deckJsonHref": "/decks/019de077-5eda-7429-9622-6655c69874f4.json",
  "deckAnchorHref": "/decks/019de077-5eda-7429-9622-6655c69874f4#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.08,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Overall Survival (OS) Kaplan-Meier curve",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6550fdee-4d24-4270-8eef-0472f350202e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.52,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Progression-Free Survival (PFS) Kaplan-Meier curve",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83fe9768-86da-4a6a-a550-2383dece21cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.85,
        "x": 0.08,
        "y": 0.7
      },
      "kind": "list",
      "text": "Key clinical findings from CARTITUDE-4 update including risk reduction and safety profile.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "065ed64b-b438-44c5-80f7-04d6a897e85e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "Mateos, et al. Overall Survival (OS) With Ciltacabtagene Autoleucel (Cilta-cel) Versus Standard of Care (SoC) in Lenalidomide-Refractory Multiple Myeloma (MM): Phase 3 CARTITUDE-4 Study Update.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "087dec48-13a9-4727-bc79-9d099778924e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.02
      },
      "kind": "title",
      "text": "CARVYKTI® - First CAR-T in MM to Achieve OS Benefit, the Gold Standard for Oncology Trials",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "54c399f5-ff7c-4496-9306-160cd3df4522",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "0db1cf35-dd39-4cc6-b3b3-feb16bfcd2ef",
      "evidence": "This slide contains a comparison of data points before and after an event, which instantiates the before-after-bridge tool.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "3f2a2246-f8ab-4742-b533-9c748a575312",
      "evidence": "Comparison of CARVYKTI vs SOC outcomes",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 6,
      "beatId": "7c8baf70-5131-4fcd-93ee-e0deff4b2b69",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Surface Observation",
      "beatSlug": "onion-surface-observation",
      "evidence": "The before-after slide compares CARVYKTI's performance to historical CAR-T launches.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}